Sebelius Kathleen
- SEC CIK
- 0001654316
In the past year, 1 open-market purchase filing worth $50.0K and no sales.
Current role at each company
- HUMA Humacyte, Inc.Directoras of Jun 12, 2026
- EXAS Exact Sciences CorpDirectoras of Dec 20, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $50.0K
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$50.0K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Sebelius Kathleen as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
HUMA Humacyte, Inc.
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 20, 2026 (view filing) | May 19 | 1 day | Sebelius KathleenDirector | PPurchase | +56.8K | $0.88 | +$50.0K | +62.3%148.0K after | |
| Apr 8, 2025 (view filing) | Apr 8 | Same day | Sebelius KathleenDirector | PPurchase | +50.0K | $1.32 | +$66.0K | +121.3%91.2K after | |
| Sep 11, 2024 (view filing) | Sep 10 | 1 day | Sebelius KathleenDirector | SSale | −5.18K | $5.40 | −$28.0K | −11.2%41.2K after | 2 lots |